Global Amyotrophic Lateral Sclerosis Therapeutics Market Growth 2019-2024

January 2019 | 137 pages | ID: GD7C7E9D146EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Amyotrophic lateral sclerosis (ALS) is also known as Lou Gehrig’s disease or Maladie De Charcot, it is a neurological disease that causes nerve cells to gradually break down and die.

According to this study, over the next five years the Amyotrophic Lateral Sclerosis Therapeutics market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2017. In particular, this report presents the global market share (sales and revenue) of key companies in Amyotrophic Lateral Sclerosis Therapeutics business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Amyotrophic Lateral Sclerosis Therapeutics market by product type, application, key manufacturers and key regions and countries.

This study considers the Amyotrophic Lateral Sclerosis Therapeutics value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2013 to 2018, in Section 2.3; and forecast to 2024 in section 11.7.

• Riluzole
• Edaravone (Radicava)
• Other

Segmentation by application: breakdown data from 2013 to 2018, in Section 2.4; and forecast to 2024 in section 11.8.

• Hospital
• Drugs Store
• Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

• Mitsubishi Tanabe Pharma
• Sanofi
• Mylan Pharma
• Apotex
• Glemark Generics
• Covis Pharma
• Sun Pharma
• Lunan Pharma

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Amyotrophic Lateral Sclerosis Therapeutics consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2024.
• To understand the structure of Amyotrophic Lateral Sclerosis Therapeutics market by identifying its various subsegments.
• Focuses on the key global Amyotrophic Lateral Sclerosis Therapeutics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Amyotrophic Lateral Sclerosis Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Amyotrophic Lateral Sclerosis Therapeutics submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Amyotrophic Lateral Sclerosis Therapeutics Consumption 2013-2023
  2.1.2 Amyotrophic Lateral Sclerosis Therapeutics Consumption CAGR by Region
2.2 Amyotrophic Lateral Sclerosis Therapeutics Segment by Type
  2.2.1 Riluzole
  2.2.2 Edaravone (Radicava)
  2.2.3 Other
2.3 Amyotrophic Lateral Sclerosis Therapeutics Consumption by Type
  2.3.1 Global Amyotrophic Lateral Sclerosis Therapeutics Consumption Market Share by Type (2013-2018)
  2.3.2 Global Amyotrophic Lateral Sclerosis Therapeutics Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Amyotrophic Lateral Sclerosis Therapeutics Sale Price by Type (2013-2018)
2.4 Amyotrophic Lateral Sclerosis Therapeutics Segment by Application
  2.4.1 Hospital
  2.4.2 Drugs Store
  2.4.3 Other
2.5 Amyotrophic Lateral Sclerosis Therapeutics Consumption by Application
  2.5.1 Global Amyotrophic Lateral Sclerosis Therapeutics Consumption Market Share by Application (2013-2018)
  2.5.2 Global Amyotrophic Lateral Sclerosis Therapeutics Value and Market Share by Application (2013-2018)
  2.5.3 Global Amyotrophic Lateral Sclerosis Therapeutics Sale Price by Application (2013-2018)

3 GLOBAL AMYOTROPHIC LATERAL SCLEROSIS THERAPEUTICS BY PLAYERS

3.1 Global Amyotrophic Lateral Sclerosis Therapeutics Sales Market Share by Players
  3.1.1 Global Amyotrophic Lateral Sclerosis Therapeutics Sales by Players (2016-2018)
  3.1.2 Global Amyotrophic Lateral Sclerosis Therapeutics Sales Market Share by Players (2016-2018)
3.2 Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Market Share by Players
  3.2.1 Global Amyotrophic Lateral Sclerosis Therapeutics Revenue by Players (2016-2018)
  3.2.2 Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Market Share by Players (2016-2018)
3.3 Global Amyotrophic Lateral Sclerosis Therapeutics Sale Price by Players
3.4 Global Amyotrophic Lateral Sclerosis Therapeutics Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Amyotrophic Lateral Sclerosis Therapeutics Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Amyotrophic Lateral Sclerosis Therapeutics Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 AMYOTROPHIC LATERAL SCLEROSIS THERAPEUTICS BY REGIONS

4.1 Amyotrophic Lateral Sclerosis Therapeutics by Regions
  4.1.1 Global Amyotrophic Lateral Sclerosis Therapeutics Consumption by Regions
  4.1.2 Global Amyotrophic Lateral Sclerosis Therapeutics Value by Regions
4.2 Americas Amyotrophic Lateral Sclerosis Therapeutics Consumption Growth
4.3 APAC Amyotrophic Lateral Sclerosis Therapeutics Consumption Growth
4.4 Europe Amyotrophic Lateral Sclerosis Therapeutics Consumption Growth
4.5 Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Consumption Growth

5 AMERICAS

5.1 Americas Amyotrophic Lateral Sclerosis Therapeutics Consumption by Countries
  5.1.1 Americas Amyotrophic Lateral Sclerosis Therapeutics Consumption by Countries (2013-2018)
  5.1.2 Americas Amyotrophic Lateral Sclerosis Therapeutics Value by Countries (2013-2018)
5.2 Americas Amyotrophic Lateral Sclerosis Therapeutics Consumption by Type
5.3 Americas Amyotrophic Lateral Sclerosis Therapeutics Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Amyotrophic Lateral Sclerosis Therapeutics Consumption by Countries
  6.1.1 APAC Amyotrophic Lateral Sclerosis Therapeutics Consumption by Countries (2013-2018)
  6.1.2 APAC Amyotrophic Lateral Sclerosis Therapeutics Value by Countries (2013-2018)
6.2 APAC Amyotrophic Lateral Sclerosis Therapeutics Consumption by Type
6.3 APAC Amyotrophic Lateral Sclerosis Therapeutics Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Amyotrophic Lateral Sclerosis Therapeutics by Countries
  7.1.1 Europe Amyotrophic Lateral Sclerosis Therapeutics Consumption by Countries (2013-2018)
  7.1.2 Europe Amyotrophic Lateral Sclerosis Therapeutics Value by Countries (2013-2018)
7.2 Europe Amyotrophic Lateral Sclerosis Therapeutics Consumption by Type
7.3 Europe Amyotrophic Lateral Sclerosis Therapeutics Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics by Countries
  8.1.1 Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Value by Countries (2013-2018)
8.2 Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Consumption by Type
8.3 Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Amyotrophic Lateral Sclerosis Therapeutics Distributors
10.3 Amyotrophic Lateral Sclerosis Therapeutics Customer

11 GLOBAL AMYOTROPHIC LATERAL SCLEROSIS THERAPEUTICS MARKET FORECAST

11.1 Global Amyotrophic Lateral Sclerosis Therapeutics Consumption Forecast (2018-2023)
11.2 Global Amyotrophic Lateral Sclerosis Therapeutics Forecast by Regions
  11.2.1 Global Amyotrophic Lateral Sclerosis Therapeutics Forecast by Regions (2018-2023)
  11.2.2 Global Amyotrophic Lateral Sclerosis Therapeutics Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Amyotrophic Lateral Sclerosis Therapeutics Forecast by Type
11.8 Global Amyotrophic Lateral Sclerosis Therapeutics Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Mitsubishi Tanabe Pharma
  12.1.1 Company Details
  12.1.2 Amyotrophic Lateral Sclerosis Therapeutics Product Offered
  12.1.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Mitsubishi Tanabe Pharma News
12.2 Sanofi
  12.2.1 Company Details
  12.2.2 Amyotrophic Lateral Sclerosis Therapeutics Product Offered
  12.2.3 Sanofi Amyotrophic Lateral Sclerosis Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Sanofi News
12.3 Mylan Pharma
  12.3.1 Company Details
  12.3.2 Amyotrophic Lateral Sclerosis Therapeutics Product Offered
  12.3.3 Mylan Pharma Amyotrophic Lateral Sclerosis Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Mylan Pharma News
12.4 Apotex
  12.4.1 Company Details
  12.4.2 Amyotrophic Lateral Sclerosis Therapeutics Product Offered
  12.4.3 Apotex Amyotrophic Lateral Sclerosis Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Apotex News
12.5 Glemark Generics
  12.5.1 Company Details
  12.5.2 Amyotrophic Lateral Sclerosis Therapeutics Product Offered
  12.5.3 Glemark Generics Amyotrophic Lateral Sclerosis Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 Glemark Generics News
12.6 Covis Pharma
  12.6.1 Company Details
  12.6.2 Amyotrophic Lateral Sclerosis Therapeutics Product Offered
  12.6.3 Covis Pharma Amyotrophic Lateral Sclerosis Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 Covis Pharma News
12.7 Sun Pharma
  12.7.1 Company Details
  12.7.2 Amyotrophic Lateral Sclerosis Therapeutics Product Offered
  12.7.3 Sun Pharma Amyotrophic Lateral Sclerosis Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 Sun Pharma News
12.8 Lunan Pharma
  12.8.1 Company Details
  12.8.2 Amyotrophic Lateral Sclerosis Therapeutics Product Offered
  12.8.3 Lunan Pharma Amyotrophic Lateral Sclerosis Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 Lunan Pharma News

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Amyotrophic Lateral Sclerosis Therapeutics
Table Product Specifications of Amyotrophic Lateral Sclerosis Therapeutics
Figure Amyotrophic Lateral Sclerosis Therapeutics Report Years Considered
Figure Market Research Methodology
Figure Global Amyotrophic Lateral Sclerosis Therapeutics Consumption Growth Rate 2013-2023 (K Units)
Figure Global Amyotrophic Lateral Sclerosis Therapeutics Value Growth Rate 2013-2023 ($ Millions)
Table Amyotrophic Lateral Sclerosis Therapeutics Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Riluzole
Table Major Players of Riluzole
Figure Product Picture of Edaravone (Radicava)
Table Major Players of Edaravone (Radicava)
Figure Product Picture of Other
Table Major Players of Other
Table Global Consumption Sales by Type (2013-2018)
Table Global Amyotrophic Lateral Sclerosis Therapeutics Consumption Market Share by Type (2013-2018)
Figure Global Amyotrophic Lateral Sclerosis Therapeutics Consumption Market Share by Type (2013-2018)
Table Global Amyotrophic Lateral Sclerosis Therapeutics Revenue by Type (2013-2018) ($ million)
Table Global Amyotrophic Lateral Sclerosis Therapeutics Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Amyotrophic Lateral Sclerosis Therapeutics Value Market Share by Type (2013-2018)
Table Global Amyotrophic Lateral Sclerosis Therapeutics Sale Price by Type (2013-2018)
Figure Amyotrophic Lateral Sclerosis Therapeutics Consumed in Hospital
Figure Global Amyotrophic Lateral Sclerosis Therapeutics Market: Hospital (2013-2018) (K Units)
Figure Global Amyotrophic Lateral Sclerosis Therapeutics Market: Hospital (2013-2018) ($ Millions)
Figure Global Hospital YoY Growth ($ Millions)
Figure Amyotrophic Lateral Sclerosis Therapeutics Consumed in Drugs Store
Figure Global Amyotrophic Lateral Sclerosis Therapeutics Market: Drugs Store (2013-2018) (K Units)
Figure Global Amyotrophic Lateral Sclerosis Therapeutics Market: Drugs Store (2013-2018) ($ Millions)
Figure Global Drugs Store YoY Growth ($ Millions)
Figure Amyotrophic Lateral Sclerosis Therapeutics Consumed in Other
Figure Global Amyotrophic Lateral Sclerosis Therapeutics Market: Other (2013-2018) (K Units)
Figure Global Amyotrophic Lateral Sclerosis Therapeutics Market: Other (2013-2018) ($ Millions)
Figure Global Other YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Amyotrophic Lateral Sclerosis Therapeutics Consumption Market Share by Application (2013-2018)
Figure Global Amyotrophic Lateral Sclerosis Therapeutics Consumption Market Share by Application (2013-2018)
Table Global Amyotrophic Lateral Sclerosis Therapeutics Value by Application (2013-2018)
Table Global Amyotrophic Lateral Sclerosis Therapeutics Value Market Share by Application (2013-2018)
Figure Global Amyotrophic Lateral Sclerosis Therapeutics Value Market Share by Application (2013-2018)
Table Global Amyotrophic Lateral Sclerosis Therapeutics Sale Price by Application (2013-2018)
Table Global Amyotrophic Lateral Sclerosis Therapeutics Sales by Players (2016-2018) (K Units)
Table Global Amyotrophic Lateral Sclerosis Therapeutics Sales Market Share by Players (2016-2018)
Figure Global Amyotrophic Lateral Sclerosis Therapeutics Sales Market Share by Players in 2016
Figure Global Amyotrophic Lateral Sclerosis Therapeutics Sales Market Share by Players in 2017
Table Global Amyotrophic Lateral Sclerosis Therapeutics Revenue by Players (2016-2018) ($ Millions)
Table Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Market Share by Players (2016-2018)
Figure Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Market Share by Players in 2016
Figure Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Market Share by Players in 2017
Table Global Amyotrophic Lateral Sclerosis Therapeutics Sale Price by Players (2016-2018)
Figure Global Amyotrophic Lateral Sclerosis Therapeutics Sale Price by Players in 2017
Table Global Amyotrophic Lateral Sclerosis Therapeutics Manufacturing Base Distribution and Sales Area by Players
Table Players Amyotrophic Lateral Sclerosis Therapeutics Products Offered
Table Amyotrophic Lateral Sclerosis Therapeutics Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Amyotrophic Lateral Sclerosis Therapeutics Consumption by Regions 2013-2018 (K Units)
Table Global Amyotrophic Lateral Sclerosis Therapeutics Consumption Market Share by Regions 2013-2018
Figure Global Amyotrophic Lateral Sclerosis Therapeutics Consumption Market Share by Regions 2013-2018
Table Global Amyotrophic Lateral Sclerosis Therapeutics Value by Regions 2013-2018 ($ Millions)
Table Global Amyotrophic Lateral Sclerosis Therapeutics Value Market Share by Regions 2013-2018
Figure Global Amyotrophic Lateral Sclerosis Therapeutics Value Market Share by Regions 2013-2018
Figure Americas Amyotrophic Lateral Sclerosis Therapeutics Consumption 2013-2018 (K Units)
Figure Americas Amyotrophic Lateral Sclerosis Therapeutics Value 2013-2018 ($ Millions)
Figure APAC Amyotrophic Lateral Sclerosis Therapeutics Consumption 2013-2018 (K Units)
Figure APAC Amyotrophic Lateral Sclerosis Therapeutics Value 2013-2018 ($ Millions)
Figure Europe Amyotrophic Lateral Sclerosis Therapeutics Consumption 2013-2018 (K Units)
Figure Europe Amyotrophic Lateral Sclerosis Therapeutics Value 2013-2018 ($ Millions)
Figure Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Consumption 2013-2018 (K Units)
Figure Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Value 2013-2018 ($ Millions)
Table Americas Amyotrophic Lateral Sclerosis Therapeutics Consumption by Countries (2013-2018) (K Units)
Table Americas Amyotrophic Lateral Sclerosis Therapeutics Consumption Market Share by Countries (2013-2018)
Figure Americas Amyotrophic Lateral Sclerosis Therapeutics Consumption Market Share by Countries in 2017
Table Americas Amyotrophic Lateral Sclerosis Therapeutics Value by Countries (2013-2018) ($ Millions)
Table Americas Amyotrophic Lateral Sclerosis Therapeutics Value Market Share by Countries (2013-2018)
Figure Americas Amyotrophic Lateral Sclerosis Therapeutics Value Market Share by Countries in 2017
Table Americas Amyotrophic Lateral Sclerosis Therapeutics Consumption by Type (2013-2018) (K Units)
Table Americas Amyotrophic Lateral Sclerosis Therapeutics Consumption Market Share by Type (2013-2018)
Figure Americas Amyotrophic Lateral Sclerosis Therapeutics Consumption Market Share by Type in 2017
Table Americas Amyotrophic Lateral Sclerosis Therapeutics Consumption by Application (2013-2018) (K Units)
Table Americas Amyotrophic Lateral Sclerosis Therapeutics Consumption Market Share by Application (2013-2018)
Figure Americas Amyotrophic Lateral Sclerosis Therapeutics Consumption Market Share by Application in 2017
Figure United States Amyotrophic Lateral Sclerosis Therapeutics Consumption Growth 2013-2018 (K Units)
Figure United States Amyotrophic Lateral Sclerosis Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Canada Amyotrophic Lateral Sclerosis Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Canada Amyotrophic Lateral Sclerosis Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Mexico Amyotrophic Lateral Sclerosis Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Mexico Amyotrophic Lateral Sclerosis Therapeutics Value Growth 2013-2018 ($ Millions)
Table APAC Amyotrophic Lateral Sclerosis Therapeutics Consumption by Countries (2013-2018) (K Units)
Table APAC Amyotrophic Lateral Sclerosis Therapeutics Consumption Market Share by Countries (2013-2018)
Figure APAC Amyotrophic Lateral Sclerosis Therapeutics Consumption Market Share by Countries in 2017
Table APAC Amyotrophic Lateral Sclerosis Therapeutics Value by Countries (2013-2018) ($ Millions)
Table APAC Amyotrophic Lateral Sclerosis Therapeutics Value Market Share by Countries (2013-2018)
Figure APAC Amyotrophic Lateral Sclerosis Therapeutics Value Market Share by Countries in 2017
Table APAC Amyotrophic Lateral Sclerosis Therapeutics Consumption by Type (2013-2018) (K Units)
Table APAC Amyotrophic Lateral Sclerosis Therapeutics Consumption Market Share by Type (2013-2018)
Figure APAC Amyotrophic Lateral Sclerosis Therapeutics Consumption Market Share by Type in 2017
Table APAC Amyotrophic Lateral Sclerosis Therapeutics Consumption by Application (2013-2018) (K Units)
Table APAC Amyotrophic Lateral Sclerosis Therapeutics Consumption Market Share by Application (2013-2018)
Figure APAC Amyotrophic Lateral Sclerosis Therapeutics Consumption Market Share by Application in 2017
Figure China Amyotrophic Lateral Sclerosis Therapeutics Consumption Growth 2013-2018 (K Units)
Figure China Amyotrophic Lateral Sclerosis Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Japan Amyotrophic Lateral Sclerosis Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Japan Amyotrophic Lateral Sclerosis Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Korea Amyotrophic Lateral Sclerosis Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Korea Amyotrophic Lateral Sclerosis Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Amyotrophic Lateral Sclerosis Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Amyotrophic Lateral Sclerosis Therapeutics Value Growth 2013-2018 ($ Millions)
Figure India Amyotrophic Lateral Sclerosis Therapeutics Consumption Growth 2013-2018 (K Units)
Figure India Amyotrophic Lateral Sclerosis Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Australia Amyotrophic Lateral Sclerosis Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Australia Amyotrophic Lateral Sclerosis Therapeutics Value Growth 2013-2018 ($ Millions)
Table Europe Amyotrophic Lateral Sclerosis Therapeutics Consumption by Countries (2013-2018) (K Units)
Table Europe Amyotrophic Lateral Sclerosis Therapeutics Consumption Market Share by Countries (2013-2018)
Figure Europe Amyotrophic Lateral Sclerosis Therapeutics Consumption Market Share by Countries in 2017
Table Europe Amyotrophic Lateral Sclerosis Therapeutics Value by Countries (2013-2018) ($ Millions)
Table Europe Amyotrophic Lateral Sclerosis Therapeutics Value Market Share by Countries (2013-2018)
Figure Europe Amyotrophic Lateral Sclerosis Therapeutics Value Market Share by Countries in 2017
Table Europe Amyotrophic Lateral Sclerosis Therapeutics Consumption by Type (2013-2018) (K Units)
Table Europe Amyotrophic Lateral Sclerosis Therapeutics Consumption Market Share by Type (2013-2018)
Figure Europe Amyotrophic Lateral Sclerosis Therapeutics Consumption Market Share by Type in 2017
Table Europe Amyotrophic Lateral Sclerosis Therapeutics Consumption by Application (2013-2018) (K Units)
Table Europe Amyotrophic Lateral Sclerosis Therapeutics Consumption Market Share by Application (2013-2018)
Figure Europe Amyotrophic Lateral Sclerosis Therapeutics Consumption Market Share by Application in 2017
Figure Germany Amyotrophic Lateral Sclerosis Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Germany Amyotrophic Lateral Sclerosis Therapeutics Value Growth 2013-2018 ($ Millions)
Figure France Amyotrophic Lateral Sclerosis Therapeutics Consumption Growth 2013-2018 (K Units)
Figure France Amyotrophic Lateral Sclerosis Therapeutics Value Growth 2013-2018 ($ Millions)
Figure UK Amyotrophic Lateral Sclerosis Therapeutics Consumption Growth 2013-2018 (K Units)
Figure UK Amyotrophic Lateral Sclerosis Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Italy Amyotrophic Lateral Sclerosis Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Italy Amyotrophic Lateral Sclerosis Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Russia Amyotrophic Lateral Sclerosis Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Russia Amyotrophic Lateral Sclerosis Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Spain Amyotrophic Lateral Sclerosis Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Spain Amyotrophic Lateral Sclerosis Therapeutics Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Consumption Market Share by Countries in 2017
Table Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Value Market Share by Countries in 2017
Table Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Consumption Market Share by Type in 2017
Table Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Consumption Market Share by Application in 2017
Figure Egypt Amyotrophic Lateral Sclerosis Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Egypt Amyotrophic Lateral Sclerosis Therapeutics Value Growth 2013-2018 ($ Millions)
Figure South Africa Amyotrophic Lateral Sclerosis Therapeutics Consumption Growth 2013-2018 (K Units)
Figure South Africa Amyotrophic Lateral Sclerosis Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Israel Amyotrophic Lateral Sclerosis Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Israel Amyotrophic Lateral Sclerosis Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Turkey Amyotrophic Lateral Sclerosis Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Turkey Amyotrophic Lateral Sclerosis Therapeutics Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Amyotrophic Lateral Sclerosis Therapeutics Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Amyotrophic Lateral Sclerosis Therapeutics Value Growth 2013-2018 ($ Millions)
Table Amyotrophic Lateral Sclerosis Therapeutics Distributors List
Table Amyotrophic Lateral Sclerosis Therapeutics Customer List
Figure Global Amyotrophic Lateral Sclerosis Therapeutics Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Amyotrophic Lateral Sclerosis Therapeutics Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Amyotrophic Lateral Sclerosis Therapeutics Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Amyotrophic Lateral Sclerosis Therapeutics Consumption Market Forecast by Regions
Table Global Amyotrophic Lateral Sclerosis Therapeutics Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Amyotrophic Lateral Sclerosis Therapeutics Value Market Share Forecast by Regions
Figure Americas Amyotrophic Lateral Sclerosis Therapeutics Consumption 2018-2023 (K Units)
Figure Americas Amyotrophic Lateral Sclerosis Therapeutics Value 2018-2023 ($ Millions)
Figure APAC Amyotrophic Lateral Sclerosis Therapeutics Consumption 2018-2023 (K Units)
Figure APAC Amyotrophic Lateral Sclerosis Therapeutics Value 2018-2023 ($ Millions)
Figure Europe Amyotrophic Lateral Sclerosis Therapeutics Consumption 2018-2023 (K Units)
Figure Europe Amyotrophic Lateral Sclerosis Therapeutics Value 2018-2023 ($ Millions)
Figure Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Consumption 2018-2023 (K Units)
Figure Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Value 2018-2023 ($ Millions)
Figure United States Amyotrophic Lateral Sclerosis Therapeutics Consumption 2018-2023 (K Units)
Figure United States Amyotrophic Lateral Sclerosis Therapeutics Value 2018-2023 ($ Millions)
Figure Canada Amyotrophic Lateral Sclerosis Therapeutics Consumption 2018-2023 (K Units)
Figure Canada Amyotrophic Lateral Sclerosis Therapeutics Value 2018-2023 ($ Millions)
Figure Mexico Amyotrophic Lateral Sclerosis Therapeutics Consumption 2018-2023 (K Units)
Figure Mexico Amyotrophic Lateral Sclerosis Therapeutics Value 2018-2023 ($ Millions)
Figure Brazil Amyotrophic Lateral Sclerosis Therapeutics Consumption 2018-2023 (K Units)
Figure Brazil Amyotrophic Lateral Sclerosis Therapeutics Value 2018-2023 ($ Millions)
Figure China Amyotrophic Lateral Sclerosis Therapeutics Consumption 2018-2023 (K Units)
Figure China Amyotrophic Lateral Sclerosis Therapeutics Value 2018-2023 ($ Millions)
Figure Japan Amyotrophic Lateral Sclerosis Therapeutics Consumption 2018-2023 (K Units)
Figure Japan Amyotrophic Lateral Sclerosis Therapeutics Value 2018-2023 ($ Millions)
Figure Korea Amyotrophic Lateral Sclerosis Therapeutics Consumption 2018-2023 (K Units)
Figure Korea Amyotrophic Lateral Sclerosis Therapeutics Value 2018-2023 ($ Millions)
Figure Southeast Asia Amyotrophic Lateral Sclerosis Therapeutics Consumption 2018-2023 (K Units)
Figure Southeast Asia Amyotrophic Lateral Sclerosis Therapeutics Value 2018-2023 ($ Millions)
Figure India Amyotrophic Lateral Sclerosis Therapeutics Consumption 2018-2023 (K Units)
Figure India Amyotrophic Lateral Sclerosis Therapeutics Value 2018-2023 ($ Millions)
Figure Australia Amyotrophic Lateral Sclerosis Therapeutics Consumption 2018-2023 (K Units)
Figure Australia Amyotrophic Lateral Sclerosis Therapeutics Value 2018-2023 ($ Millions)
Figure Germany Amyotrophic Lateral Sclerosis Therapeutics Consumption 2018-2023 (K Units)
Figure Germany Amyotrophic Lateral Sclerosis Therapeutics Value 2018-2023 ($ Millions)
Figure France Amyotrophic Lateral Sclerosis Therapeutics Consumption 2018-2023 (K Units)
Figure France Amyotrophic Lateral Sclerosis Therapeutics Value 2018-2023 ($ Millions)
Figure UK Amyotrophic Lateral Sclerosis Therapeutics Consumption 2018-2023 (K Units)
Figure UK Amyotrophic Lateral Sclerosis Therapeutics Value 2018-2023 ($ Millions)
Figure Italy Amyotrophic Lateral Sclerosis Therapeutics Consumption 2018-2023 (K Units)
Figure Italy Amyotrophic Lateral Sclerosis Therapeutics Value 2018-2023 ($ Millions)
Figure Russia Amyotrophic Lateral Sclerosis Therapeutics Consumption 2018-2023 (K Units)
Figure Russia Amyotrophic Lateral Sclerosis Therapeutics Value 2018-2023 ($ Millions)
Figure Spain Amyotrophic Lateral Sclerosis Therapeutics Consumption 2018-2023 (K Units)
Figure Spain Amyotrophic Lateral Sclerosis Therapeutics Value 2018-2023 ($ Millions)
Figure Egypt Amyotrophic Lateral Sclerosis Therapeutics Consumption 2018-2023 (K Units)
Figure Egypt Amyotrophic Lateral Sclerosis Therapeutics Value 2018-2023 ($ Millions)
Figure South Africa Amyotrophic Lateral Sclerosis Therapeutics Consumption 2018-2023 (K Units)
Figure South Africa Amyotrophic Lateral Sclerosis Therapeutics Value 2018-2023 ($ Millions)
Figure Israel Amyotrophic Lateral Sclerosis Therapeutics Consumption 2018-2023 (K Units)
Figure Israel Amyotrophic Lateral Sclerosis Therapeutics Value 2018-2023 ($ Millions)
Figure Turkey Amyotrophic Lateral Sclerosis Therapeutics Consumption 2018-2023 (K Units)
Figure Turkey Amyotrophic Lateral Sclerosis Therapeutics Value 2018-2023 ($ Millions)
Figure GCC Countries Amyotrophic Lateral Sclerosis Therapeutics Consumption 2018-2023 (K Units)
Figure GCC Countries Amyotrophic Lateral Sclerosis Therapeutics Value 2018-2023 ($ Millions)
Table Global Amyotrophic Lateral Sclerosis Therapeutics Consumption Forecast by Type (2018-2023) (K Units)
Table Global Amyotrophic Lateral Sclerosis Therapeutics Consumption Market Share Forecast by Type (2018-2023)
Table Global Amyotrophic Lateral Sclerosis Therapeutics Value Forecast by Type (2018-2023) ($ Millions)
Table Global Amyotrophic Lateral Sclerosis Therapeutics Value Market Share Forecast by Type (2018-2023)
Table Global Amyotrophic Lateral Sclerosis Therapeutics Consumption Forecast by Application (2018-2023) (K Units)
Table Global Amyotrophic Lateral Sclerosis Therapeutics Consumption Market Share Forecast by Application (2018-2023)
Table Global Amyotrophic Lateral Sclerosis Therapeutics Value Forecast by Application (2018-2023) ($ Millions)
Table Global Amyotrophic Lateral Sclerosis Therapeutics Value Market Share Forecast by Application (2018-2023)
Table Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Therapeutics Market Share (2016-2018)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Amyotrophic Lateral Sclerosis Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sanofi Amyotrophic Lateral Sclerosis Therapeutics Market Share (2016-2018)
Table Mylan Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mylan Pharma Amyotrophic Lateral Sclerosis Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Mylan Pharma Amyotrophic Lateral Sclerosis Therapeutics Market Share (2016-2018)
Table Apotex Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Apotex Amyotrophic Lateral Sclerosis Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Apotex Amyotrophic Lateral Sclerosis Therapeutics Market Share (2016-2018)
Table Glemark Generics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Glemark Generics Amyotrophic Lateral Sclerosis Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Glemark Generics Amyotrophic Lateral Sclerosis Therapeutics Market Share (2016-2018)
Table Covis Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Covis Pharma Amyotrophic Lateral Sclerosis Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Covis Pharma Amyotrophic Lateral Sclerosis Therapeutics Market Share (2016-2018)
Table Sun Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sun Pharma Amyotrophic Lateral Sclerosis Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sun Pharma Amyotrophic Lateral Sclerosis Therapeutics Market Share (2016-2018)
Table Lunan Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Lunan Pharma Amyotrophic Lateral Sclerosis Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Lunan Pharma Amyotrophic Lateral Sclerosis Therapeutics Market Share (2016-2018)